Figure 1

Detection of PCV4 from clinical cases submitted to the ISU-VDL from June–September 2023. Multiple sample types were evaluated for the presence of PCV4 by qPCR (A). Average distribution of Ct values amongst different sample types. No significant difference (p > 0.05) in the average Ct value was observed amongst different sample types (B). Significance was established at p < 0.05.